Business
Notice of General Meeting
Notice of General Meeting.
About this update from Agronomics Limited
[{"type":"text","content":"\n \nRNS Number : 2455R Port Erin Biopharma Investments Ltd 24 October 2013 \n \n\nPort Erin Biopharma Investments Limited\n(\"PEBI\" or the \"Company\")\nNotice of Meeting of Shareholders\nProposed change of the Company's existing investing policy\nPort Erin Biopharma Investments Limited (AIM: PEBI) is pleased to announce that it is convening a meeting of the Company's shareholders (\"Meeting\") to consider, and if thought fit, approve a proposed change of the Company's existing investment policy.\nPEBI's Board believes that the proposed new investing policy reflects the preferred strategy of the Company moving forward whist providing the Company's shareholders the opportunity to eliminate the discount to Net Asset Value reflected in the Company's share price. The proposed investing policy would permit the Directors to make an in specie exchange of all the Company's qualifying assets into a UCITS fund, the Magna Biopharma Income Fund, followed by a further meeting of the Company's shareholders in one year's time, to consider the pro rata distribution of the UCITS fund's shares to the Company's shareholders or the pro rata distribution of the equivalent amount in cash. The Company will still continue to trade on AIM and the Board will continue to review potential investment or acquisition opportunities in line with the proposed new investing policy but has not, at this stage, entered into any firm commitment in connection with any investments or acquisitions.\nThe Directors believe that current market conditions will provide good opportunities for a positive return from the above investments in the Biopharma sector.\nThe Meeting is to be held in the Sanderson Suite, the Claremont Hotel, 18-22 Loch Promenade, Douglas, Isle of Man IM1 2LX at 10:00 a.m. GMT on 11 November 2013. The circular containing the Notice of Meeting and the full text of the proposed investing policy is being posted to shareholders today and will be shortly available on the Company's website www.porterinbiopharma.com.\nContact details:-\n\n\n\n\nPort Erin Biopharma Investment Limited\n\n\nLibertas Capital Corporate Finance Limited\n\n\nPeterhouse Corporate Finance Limited\n\n\n\n\nDenham Eke\n\n\nSandy Jamieson\n\n\nJon Levenson\n\n\n\n\n+44 (0) 1624 639396\n\n\n0203 697 9495\n\n\n0207 469 0930\n\n\n\n\n \nThe full text of the proposed investi...